Artículos por temáticas
En este apartado encontrará una actualización mensual de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.
FILTRAR POR:
Tema
Diagnosis
326 ARTíCULOS , VIENDO DEL 121 AL 135
Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly
Randall C, Mosconi L, de Leon M, Glodzik L.
Front Biosci (Landmark Ed). 2013 Jun 1;18(3):1150-73. doi: 10.2741/4170.
0
0
0
Perturbations of neural circuitry in aging, mild cognitive impairment, and Alzheimer's disease
Leal SL, Yassa MA.
Ageing Res Rev. 2013 Jun;12(3):823-31. doi: 10.1016/j.arr.2013.01.006. Epub 2013 Feb 4.
0
0
0
Aripiprazole in the treatment of Alzheimer's disease
De Deyn PP, Drenth AF, Kremer BP, Oude Voshaar RC, Van Dam D.
Expert Opin Pharmacother. 2013 Mar;14(4):459-74. doi: 10.1517/14656566.2013.764989. Epub 2013 Jan 28.
0
0
0
Clinical assessment of amyloid imaging in Alzheimer's disease: a systematic review of the literature
Wahlster P, Niederländer C, Kriza C, Schaller S, Kolominsky-Rabas PL.
Dement Geriatr Cogn Disord. 2013;36(5-6):263-78. doi: 10.1159/000351679. Epub 2013 Aug 16.
0
0
0
Cervical dystonia in an Alzheimer's disease patient treated with donepezil
Yagi Y, Watanabe Y, Yokote H, Amino T, Kamata T.
Acta Neurol Belg. 2013 Sep;113(3):363-4. doi: 10.1007/s13760-012-0143-9. Epub 2012 Oct 11.
0
0
0
The development of effective biomarkers for Alzheimer's disease: a review
Henry MS, Passmore AP, Todd S, McGuinness B, Craig D, Johnston JA.
Int J Geriatr Psychiatry. 2013 Apr;28(4):331-40. doi: 10.1002/gps.3829. Epub 2012 Jun 4.
0
0
0
Learning in Alzheimer's disease is facilitated by social interaction
Duff MC, Gallegos DR, Cohen NJ, Tranel D.
J Comp Neurol. 2013 Dec 15;521(18):4356-69. doi: 10.1002/cne.23433.
0
0
0
Effects of aging and Alzheimer's disease along the longitudinal axis of the hippocampus
Gordon BA, Blazey T, Benzinger TL, Head D.
J Alzheimers Dis. 2013;37(1):41-50. doi: 10.3233/JAD-130011.
0
0
0
Executive functions can help when deciding on the frontotemporal dementia diagnosis
Salmon DP, Stuss DT.
Neurology. 2013 Jun 11;80(24):2174-5. doi: 10.1212/WNL.0b013e318296ea38. Epub 2013 May 8.
0
0
0
Association between EXOC3L2 rs597668 polymorphism and Alzheimer's disease
Shang H, Fu J, Zhang XM, Song RR, Wang WZ.
CNS Neurosci Ther. 2013 Oct;19(10):834-9. doi: 10.1111/cns.12119. Epub 2013 May 11.
0
0
0
Sansoni J, Anderson KH, Varona LM, Varela G.
Ann Ig. 2013 May-Jun;25(3):235-46. doi: 10.7416/ai.2013.1926.
0
0
0
Leveraging global resources to end the Alzheimer's pandemic
Carrillo MC.
Alzheimers Dement. 2013 Jul;9(4):363-5. doi: 10.1016/j.jalz.2013.05.1768.
0
0
0
How it all started: tau and protein phosphatase 2A
Liu C, Götz J.
J Alzheimers Dis. 2013;37(3):483-94. doi: 10.3233/JAD-130503.
0
0
0
Alzheimer disease: current concepts & future directions
Musiek ES, Schindler SE.
Mo Med. 2013 Sep-Oct;110(5):395-400.
0
0
0
Presenilin-1 mutations in Alzheimer's disease: an update on genotype-phenotype relationships
Larner AJ.
J Alzheimers Dis. 2013;37(4):653-9. doi: 10.3233/JAD-130746.
0
0
0
Comentarios
En ningún caso la información facilitada constituye asesoramiento por parte de Zambon
Con el aval de:
En colaboración con:
